Ingalls Memorial Hospital is a general medical and surgical hospital located in Harvey, Illinois, a south suburb of Chicago, Illinois. Ingalls is a secular establishment. In 2016, Ingalls completed a merger with the University of Chicago Medicine.

During the past decade, Ingalls Memorial Hospital conducted 106 clinical trials. In the 10-year time frame, 106 clinical trials started and 135 clinical trials were completed, i.e. on average, 127.4% percent of trials that started reached the finish line to date. In the past 5 years, 31 clinical trials started and 60 clinical trials were completed. i.e. 193.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Ingalls Memorial Hospital" #1 sponsor was "National Cancer Institute (NCI)" with 86 trials, followed by "Radiation Therapy Oncology Group" with 50 trials sponsored, "Alliance for Clinical Trials in Oncology" with 26 trials sponsored, "SWOG Cancer Research Network" with 20 trials sponsored and "Hoffmann-La Roche" with 20 trials sponsored. Other sponsors include 106 different institutions and companies that sponsored additional 53 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Ingalls Memorial Hospital" #1 collaborator was "National Cancer Institute (NCI)" with 139 trials as a collaborator, "NRG Oncology" with 24 trials as a collaborator, "Cancer and Leukemia Group B" with 9 trials as a collaborator, "NCIC Clinical Trials Group" with 9 trials as a collaborator and "North Central Cancer Treatment Group" with 9 trials as a collaborator. Other collaborators include 99 different institutions and companies that were collaborators in the rest 71 trials.

According to Clinical.Site data, the most researched conditions in "Ingalls Memorial Hospital" are "Breast Cancer" (26 trials), "Head and Neck Cancer" (20 trials), "Prostate Cancer" (15 trials), "Colorectal Cancer" (14 trials) and "Lung Cancer" (13 trials). Many other conditions were trialed in "Ingalls Memorial Hospital" in a lesser frequency.

Most popular intervention types in "Ingalls Memorial Hospital" are "Drug" (256 trials), "Other" (120 trials), "Biological" (76 trials), "Radiation" (69 trials) and "Procedure" (61 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (59 trials), "Quality-of-Life Assessment" (39 trials), "radiation therapy" (36 trials), "Placebo" (27 trials) and "Carboplatin" (24 trials). Other intervention names were less common.

The vast majority of trials in "Ingalls Memorial Hospital" are 250 trials for "All" genders, 39 trials for "Female" genders and 20 trials for "Male" genders.

Currently, there are NaN active trials in "Ingalls Memorial Hospital". undefined are not yet recruiting, 30 are recruiting, 81 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 162 completed trials in Ingalls Memorial Hospital, 2 suspended trials, and 28 terminated clinical trials to date.

Out of the total trials that were conducted in Ingalls Memorial Hospital, 31 "Phase 1" clinical trials were conducted, 140 "Phase 2" clinical trials and 142 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 11 trials that are defined as “Not Applicable".